CASE REPORT
===========

A 79-year-old man was admitted due to severe chest pain and dyspnea for 3 days. The patient\'s medical history showed that he had undergone treatment for sustained ventricular tachycardia six years ago. The patient had been taking hypertension medicine.

During the evaluation, the patient complained of mild chest pain. Preoperative chest radiography showed cardiomegaly and aortic arch calcification ([Fig. 1](#F1){ref-type="fig"}). Electrocardiography showed a normal sinus rhythm. Echocardiography showed an ejection fraction of 31%, severe aortic valve stenosis (V max=5.26 m/sec, mean pressure gradient \[PG\]=69.4 mmHg, aortic valve area by continuity equation=0.6 cm^2^) and mild to moderate mitral valve regurgitation (proximal isovelocity surface area radius=0.7 cm). Coronary angiography showed no significant coronary artery disease, while chest computed tomography showed calcification of the posterior wall of the ascending aorta ([Fig. 2](#F2){ref-type="fig"}). The patient underwent surgery under general anesthesia via median sternotomy. After pericardiotomy, arterial cannulation was accomplished in the right axillary artery.

Venous drainage was accomplished with a single double-staged cavoatrial cannula. A vent cannula was inserted into the left ventricle via the right superior pulmonary vein. A root cannula was inserted into the ascending aorta. A thoracic endovascular aortic repair (TEVAR) balloon catheter (40×30 mm) for endo-aortic occlusion was inserted into the ascending aorta via the left superficial femoral artery using a C-arm (GE, Bayern, Germany) ([Fig. 3](#F3){ref-type="fig"}). After initiation of cardiopulmonary bypass (CPB) with moderate hypothermia, endo-aortic occlusion was accomplished by inflation of the TEVAR balloon ([Fig. 3](#F3){ref-type="fig"}). Blood cardioplegia solution was administered to arrest the heart via root cannula, and then this solution was administered via direct cardioplegia cannula every 20 minutes. Aortic valve replacement was performed with valve tissue. Termination of CPB was performed without complication.

The patient was extubated on the first postoperative day. Follow-up echocardiography showed an ejection fraction of 33%, a well-functioning aortic prosthetic valve (mean PG=22.4 mmHg) and minimal mitral valve regurgitation. The patient recovered without complication and was discharged on the eleventh postoperative day.

DISCUSSION
==========

As an increasing number of older patients undergo cardiac operations, severe atherosclerosis of the ascending aorta has been appearing more frequently. As much as 13% of the patients undergoing cardiac surgery will have a significant associated atheromatous disease of the ascending aorta \[[@B1]\]. In a patient with severe atherosclerosis of the ascending aorta, conventional aortic valve surgery can be technically demanding and is associated with high morbidity and mortality. To clamp an atherosclerotic aorta during a cardiac operation can increase the risk of cerebral embolism by atherosclerotic debris. Therefore, aortic valve surgery in a patient with severe atherosclerosis of the ascending aorta requires modifications of techniques for CPB.

Several reports have described modifications of surgical techniques for managing aortic valve disease in limited numbers of patients with a severely calcified ascending aorta. Gillinov et al. \[[@B2]\] reported on 62 of 4,983 patients that had undergone an aortic valve replacement and were noted to have atherosclerosis of the ascending aorta. Hypothermic circulatory arrest (HCA) including ascending aortic endarterectomy, ascending aortic replacement, and balloon occlusion of the ascending aorta were used for the patients \[[@B2]\]. Byrne et al. \[[@B3]\] have described a \"no-touch\" technique under deep HCA for the porcelain aorta. Svensson et al. \[[@B4]\] reported successful aortic endarterectomy to facilitate aortic valve replacement with a calcified ascending aorta. Cosgrove \[[@B5]\] reported a forward-balloon occlusion of the ascending aorta after performing an aortotomy with the aid of HCA.

Although various surgical strategies have been described for managing atherosclerotic aorta in patients requiring aortic valve replacement, the appropriate techniques are unknown. In addition, these strategies all need HCA. Okamoto et al. \[[@B6]\] have described HCA as a useful method for replacing the aortic valve in a patient with an atherosclerotic aorta. However, it has a limitation in its safe duration without ischemic injury occurring to the brain, and longer cardiac arrest time is also associated with high mortality and morbidity \[[@B6]\]. In our case, we performed aortic valve replacement using retrograde endoaortic balloon occlusion without HCA. This is the first such case in Korea. Abe et al. \[[@B7]\] reported that four valve surgeries were performed with balloon occlusion without HCA. We maintained the patient\'s body at a temperature of about 32℃, unlike during HCA. This procedure was performed successfully, and postoperatively, the patient recovered without any complications. Although this technique still has a greater risk of dislodging emboli than the \"no-touch\" technique under HCA, we believe that it was effective and could be a good option for high-risk patients who have a pathology of the ascending aorta while reducing the risk of cerebral embolism and without the burden of HCA. Future studies will be required to ascertain the safety of endoaortic balloon occlusion.
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![This figure shows the preoperative simple chest radiography.](kjtcs-46-212-g001){#F1}

![Preoperative computed tomographiy showed severe calcification of the aorta.](kjtcs-46-212-g002){#F2}

![Intraoperative X-ray view of endoaortic balloon occlusion. (A) Catheter inserted through right femoral artery. (B) Balloon is positioned in the ascending aorta.](kjtcs-46-212-g003){#F3}
